Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism
Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S153878362600629X?dgcid=rss_sd_all
Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S153878362600629X?dgcid=rss_sd_all
“Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism.” Journal of Thrombosis and Haemostasis.
@article{article98960,
title = {Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S153878362600629X?dgcid=rss_sd_all}
}